Changes related to "Pegylated liposomal doxorubicin (Doxil)"
This is a list of changes made recently to pages linked from a specified page (or to members of a specified category). Pages on your watchlist are bold.
10 December 2018
| m 15:26 | Hodgkin lymphoma (2 changes | history) . . (+1,691) . . [Jwarner (2×)] | |
| m | 15:26 (cur | prev) . . (+1,112) . . Jwarner (talk | contribs) (→Flu-Mel, then allo HSCT {{#subobject:6f8499|Regimen=1}}) | |
| m | 13:06 (cur | prev) . . (+579) . . Jwarner (talk | contribs) (→MOPP {{#subobject:bcde0|Regimen=1}}) |
| m 12:50 | Esophageal cancer (diff | hist) . . (+1,289) . . Jwarner (talk | contribs) |
9 December 2018
8 December 2018
| m 20:46 | Vascular sarcoma (diff | hist) . . (+1,360) . . Jwarner (talk | contribs) (→ABV {{#subobject:4531b5|Regimen=1}}) |
| m 20:04 | Ovarian cancer (diff | hist) . . (+3,960) . . Jwarner (talk | contribs) (→Paclitaxel monotherapy {{#subobject:57d35e|Regimen=1}}) |
7 December 2018
| m 13:01 | Endometrial cancer (4 changes | history) . . (+2,014) . . [Jwarner (4×)] | |
| m | 13:01 (cur | prev) . . (+714) . . Jwarner (talk | contribs) (→Endocrine therapy for advanced, recurrent, or metastatic disease) | |
| m | 12:13 (cur | prev) . . (+706) . . Jwarner (talk | contribs) (→Medroxyprogesterone acetate monotherapy {{#subobject:6c7bb9|Regimen=1}}) | |
| m | 10:03 (cur | prev) . . (+594) . . Jwarner (talk | contribs) (→Doxorubicin monotherapy {{#subobject:e5b103|Regimen=1}}) | |
| m | 09:55 (cur | prev) . . (0) . . Jwarner (talk | contribs) (→Whole abdominal radiation (WAI) {{#subobject:37c051|Regimen=1}}) |
| m 09:49 | Diffuse large B-cell lymphoma (9 changes | history) . . (+2,856) . . [Jwarner (9×)] | |
| m | 09:49 (cur | prev) . . (+279) . . Jwarner (talk | contribs) | |
| m | 09:48 (cur | prev) . . (+134) . . Jwarner (talk | contribs) (→Vinorelbine monotherapy {{#subobject:29c647|Regimen=1}}) | |
| m | 09:47 (cur | prev) . . (+676) . . Jwarner (talk | contribs) (→Rituximab monotherapy {{#subobject:d826ec|Regimen=1}}) | |
| m | 09:44 (cur | prev) . . (+124) . . Jwarner (talk | contribs) (→Variant #1, 100 mg/m2 {{#subobject:1fc8c3|Variant=1}}) | |
| m | 09:43 (cur | prev) . . (+124) . . Jwarner (talk | contribs) (→Ifosfamide monotherapy {{#subobject:b9a669|Regimen=1}}) | |
| m | 09:41 (cur | prev) . . (+134) . . Jwarner (talk | contribs) (→Variant #3, indefinite 3 out of 4 weeks {{#subobject:4d3a21|Variant=1}}) | |
| m | 09:40 (cur | prev) . . (+642) . . Jwarner (talk | contribs) (→Etoposide monotherapy {{#subobject:1ed00b|Regimen=1}}) | |
| m | 09:13 (cur | prev) . . (+135) . . Jwarner (talk | contribs) (→Variant #1, 750/300/800/800/140 {{#subobject:9131e1|Variant=1}}) | |
| m | 09:08 (cur | prev) . . (+608) . . Jwarner (talk | contribs) (→R-CHOEP-14 {{#subobject:75c24e|Regimen=1}}) |
6 December 2018
| m 23:19 | Hodgkin lymphoma (6 changes | history) . . (+2,282) . . [Warner-admin; Jwarner (5×)] | |
| m | 23:19 (cur | prev) . . (+673) . . Jwarner (talk | contribs) (→ChlVPP/EVA {{#subobject:8ee324|Regimen=1}}) | |
| m | 23:11 (cur | prev) . . (+693) . . Jwarner (talk | contribs) (→Observation) | |
| m | 22:58 (cur | prev) . . (+838) . . Jwarner (talk | contribs) | |
| m | 21:22 (cur | prev) . . (0) . . Jwarner (talk | contribs) (→Placebo) | |
| m | 20:18 (cur | prev) . . (+14) . . Jwarner (talk | contribs) (→References) | |
| m | 19:40 (cur | prev) . . (+64) . . Warner-admin (talk | contribs) (Text replacement - "http://www.nejm.org" to "https://www.nejm.org") |
| m 20:57 | HIV-associated lymphoma (2 changes | history) . . (+82) . . [Jwarner; Warner-admin] | |
| m | 20:57 (cur | prev) . . (+78) . . Jwarner (talk | contribs) (→R-CODOX-M/R-IVAC {{#subobject:9268b2|Regimen=1}}) | |
| m | 19:53 (cur | prev) . . (+4) . . Warner-admin (talk | contribs) (Text replacement - "http://www.nejm.org" to "https://www.nejm.org") |
| m 20:24 | Ovarian cancer (3 changes | history) . . (-18,884) . . [Warner-admin; Jwarner (2×)] | |
| m | 20:24 (cur | prev) . . (+509) . . Jwarner (talk | contribs) (→Paclitaxel monotherapy {{#subobject:57d35e|Regimen=1}}) | |
| m | 19:27 (cur | prev) . . (+27) . . Warner-admin (talk | contribs) (Text replacement - "http://www.nejm.org" to "https://www.nejm.org") | |
| m | 19:18 (cur | prev) . . (-19,420) . . Jwarner (talk | contribs) |
| m 20:20 | Vascular sarcoma (diff | hist) . . (+27) . . Jwarner (talk | contribs) (→References) |
| m 19:50 | Diffuse large B-cell lymphoma (3 changes | history) . . (+1,825) . . [Warner-admin; Jwarner (2×)] | |
| m | 19:50 (cur | prev) . . (+11) . . Warner-admin (talk | contribs) (Text replacement - "http://www.nejm.org" to "https://www.nejm.org") | |
| m | 13:59 (cur | prev) . . (+1,467) . . Jwarner (talk | contribs) (→R-CHOP-14 {{#subobject:fc3bde|Regimen=1}}) | |
| m | 13:45 (cur | prev) . . (+347) . . Jwarner (talk | contribs) (→R-CHOP {{#subobject:240cc2|Regimen=1}}) |
| m 19:38 | Breast cancer (diff | hist) . . (+83) . . Warner-admin (talk | contribs) (Text replacement - "http://www.nejm.org" to "https://www.nejm.org") |
| m 19:27 | Esophageal cancer (diff | hist) . . (+42) . . Warner-admin (talk | contribs) (Text replacement - "http://www.nejm.org" to "https://www.nejm.org") |
5 December 2018
| m 20:45 | Breast cancer (5 changes | history) . . (+3,208) . . [Jwarner (5×)] | |
| m | 20:45 (cur | prev) . . (-1) . . Jwarner (talk | contribs) (→Variant #1, 80 mg/m2 weekly {{#subobject:718d5b|Variant=1}}) | |
| m | 20:44 (cur | prev) . . (+322) . . Jwarner (talk | contribs) (→Docetaxel & Gemcitabine {{#subobject:031a92|Regimen=1}}) | |
| m | 18:53 (cur | prev) . . (+2,325) . . Jwarner (talk | contribs) | |
| m | 16:10 (cur | prev) . . (+228) . . Jwarner (talk | contribs) (→CMF {{#subobject:fb4c46|Regimen=1}}) | |
| m | 16:00 (cur | prev) . . (+334) . . Jwarner (talk | contribs) (→AC {{#subobject:77b0fd|Regimen=1}}) |
| m 09:46 | Diffuse large B-cell lymphoma (2 changes | history) . . (+218) . . [Jwarner (2×)] | |
| m | 09:46 (cur | prev) . . (+9) . . Jwarner (talk | contribs) (→References) | |
| m | 09:43 (cur | prev) . . (+209) . . Jwarner (talk | contribs) (→Axicabtagene ciloleucel monotherapy {{#subobject:78231d|Regimen=1}}) |
4 December 2018
| m 23:25 | Endometrial cancer (5 changes | history) . . (+2,711) . . [Jwarner (5×)] | |
| m | 23:25 (cur | prev) . . (+7,875) . . Jwarner (talk | contribs) (→Adjuvant chemoradiotherapy) | |
| m | 23:24 (cur | prev) . . (-2,068) . . Jwarner (talk | contribs) (→CIM {{#subobject:ac4dbb|Regimen=1}}) | |
| m | 23:20 (cur | prev) . . (-827) . . Jwarner (talk | contribs) (→Cisplatin & Doxorubicin {{#subobject:7f9e48|Regimen=1}}) | |
| m | 23:18 (cur | prev) . . (+111) . . Jwarner (talk | contribs) (→Tamoxifen monotherapy {{#subobject:ab84a1|Regimen=1}}) | |
| m | 23:18 (cur | prev) . . (-2,380) . . Jwarner (talk | contribs) (→Radiotherapy for advanced, recurrent, or metastatic disease) |
| m 13:17 | Ovarian cancer (2 changes | history) . . (+5,557) . . [Jwarner (2×)] | |
| m | 13:17 (cur | prev) . . (+3,640) . . Jwarner (talk | contribs) | |
| m | 12:17 (cur | prev) . . (+1,917) . . Jwarner (talk | contribs) (→Carboplatin & Paclitaxel {{#subobject:dd35ee|Regimen=1}}) |
